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A B S T R A C T
Parkinson’s disease (PD) is more commonly associated with its motor symptoms and the related degener-
ation of dopamine (DA) neurons. However, it is becoming increasingly clear that PD patients also display a
wide range of non-motor symptoms, including memory deﬁcits and disruptions of their sleep-wake cycles.
These have a large impact on their quality of life, and often precede the onset of motor symptoms, but their
etiology is poorly understood. The fruit ﬂy Drosophila has already been successfully used to model PD, and
has been used extensively to study relevant non-motor behaviours in other contexts, but little attention has
yet been paid to modelling non-motor symptoms of PD in this genetically tractable organism. We examined
memory performance and circadian rhythms in ﬂies with loss-of-functionmutations in two PD genes: PINK1
and parkin. We found learning and memory abnormalities in both mutant genotypes, as well as a weaken-
ing of circadian rhythms that is underpinned by electrophysiological changes in clock neurons. Our study
paves the way for further work that may help us understand the mechanisms underlying these neglected
aspects of PD, thus identifying new targets for treatments to address these non-motor problems speciﬁcally
and perhaps even to halt disease progression in its prodromal phase.
© 2017 Published by Elsevier Inc.
1. Introduction
Parkinson’s disease (PD) is more commonly associated with its
debilitating motor symptoms, which include tremor, rigidity and
slowness of movement. These symptoms have been linked with the
degeneration of dopamine (DA) neurons, and thus treatments for
the disease have primarily been developed to treat symptoms by
compensating for depleted levels of DA in the brain. However, it
is becoming increasingly clear that PD patients also display a wide
range of non-motor symptoms that most treatments are not specif-
ically designed to address and may even make worse (Chaudhuri
et al., 2006a,b; Langston, 2006). These include problems related to
Abbreviations: DD, Constant darkness; D/NI, Diurnal/nocturnal index; DA,
Dopamine; DAM2, Drosophila Activity Monitor; l-LNv, Large ventral lateral neu-
rons; LD, 12:12 h light-dark cycle; Rin, Membrane input resistance; MCH, 4-
methylcyclohexanol; PD, Parkinson’s disease; PI, Performance Index; PINK1, PTEN-
induced putative kinase 1; OCT, 3-octanol; RBD , REM sleep behaviour disorder; RMP,
Resting Membrane Potential; RS, Rhythmicity statistic; SFR, Spontaneous ﬁring rate;
ZT, Zeitgeber time.
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cognition and disruption of the sleep-wake cycle. Cognitive impair-
ments include memory problems and abnormalities related to rein-
forcement learning, in which DA is known to play an important role
(Barone et al., 2011; Frank et al., 2004). Sleep impairments are par-
ticularly common, affecting up to two-thirds of PD patients, and
include disorders such as insomnia, excessive daytime sleepiness
and REM sleep behaviour disorder (RBD) (Barone et al., 2009; Mattis
and Sehgal, 2016; Menza et al., 2010).
These aspects of the disease have typically attracted less attention
than the hallmark motor symptoms, but there is growing interest in
understanding how they arise, as they have a large impact on the
quality of life of both patients and their carers, and their appear-
ance can often precede the onset of motor symptoms (Barone et al.,
2009). RBD in particular is thought to be a strong predictor of PD and
dementia (Iranzo et al., 2013; Schenck et al., 2013). However, the eti-
ology of non-motor symptoms is still poorly understood. It is not yet
clear the extent to which they too result directly from the degenera-
tion of DA neurons, as opposed to the dysfunction of other cell types.
Matters are further complicated by possible adverse effects of med-
ication and of the different symptoms on one another. For instance,
symptoms of depression, which are commonly found in patients,
may in turn cause sleep problems themselves, as can taking L-dopa
http://dx.doi.org/10.1016/j.nbd.2017.04.014
0969-9961/© 2017 Published by Elsevier Inc.
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medication at bed time. The beneﬁts of using a simple, genetically
tractable model organism in a controlled environment are clear in
the face of such complications.
Although most cases of PD have no identiﬁable cause, some
genetic mutations have been linked to familial cases of the disease,
of which many affect genes that have homologs in the ﬂy (Lu and
Vogel, 2009). Here, we focus particularly on two genetic ﬂy mod-
els of PD, with mutations in genes that are thought to act together
in a mitochondrial quality control pathway: PTEN-induced putative
kinase 1 (PINK1) and the E3 ubiquitin ligase parkin. It is thought
that PINK1 accumulates on the outer membrane of damaged mito-
chondria, where it activates parkin, leading to the ubiquitination of
parkin targets on the outer mitochondrial membrane. This ultimately
results in the recruitment of autophagic machinery to degrade the
defective mitochondria (von Stockum et al., 2016). It is thought that
mitochondrial quality control may be particularly important in DA
neurons, which are susceptible to oxidative stress (Subramaniam and
Chesselet, 2013).
Loss-of-function mutations in PINK1 and parkin in humans cause
early-onset forms of PD (Kitada et al., 1998; Valente et al., 2004).
Few studies have yet explored the impact of speciﬁc mutations
on non-motor symptoms, but evidence suggests that patients with
homozygous parkin mutations exhibit the usual range of PD sleep
disorders (Limousin et al., 2009). Drosophila PINK1 and parkin loss-
of-function mutants exhibit a set of relevant phenotypes such
as impaired locomotor activity, reduced longevity, mitochondrial
abnormalities, and DA neuron degeneration (Greene et al., 2003;
Park et al., 2006; Pesah et al., 2004; Whitworth et al., 2005; Yang et
al., 2006). Neurophysiological studies are still in their infancy, but
have detected abnormalities in synaptic signalling in larvae (West et
al., 2015). Interestingly, rodent loss-of-function models have largely
failed to replicate the hallmark symptoms of PD (Dawson et al.,
2010).
Drosophila display many behaviours that are pertinent to mod-
elling human disease, which are underlied by simple, tractable neu-
ral circuits. Learning andmemory has been extensively studied using
an olfactory associative learning assay, and DA has been shown to
play a crucial role, as it does in mammals (Malik and Hodge, 2014;
Tully and Quinn, 1985; Waddell, 2010). The ﬂy has also been cen-
tral to ongoing chronobiology research. Wild type ﬂies are diurnal
and show robust circadian rhythms in their activity in the absence
of external time cues, their locomotor activity thus providing a con-
venient output of their internal clock (Rosato and Kyriacou, 2006).
These behavioural ﬂuctuations appear to be partly underpinned by
ﬂuctuations in the electrophysiological properties of pacemaker neu-
rons expressing the neuropeptide pigment dispersing factor (PDF),
including the large ventral lateral neurons (l-LNvs) (Peschel and Hel-
frich-Förster, 2011). These thus represent deﬁned neurons in the
clock neural circuit that can be recorded from (Buhl et al. 2016; Chen
et al. 2015).
Despite these conserved behaviours, little attention has been
paid to modelling non-motor symptoms of PD in Drosophila, except
for two studies using ﬂies expressing mutated form of the human
PD-related gene a-synuclein throughout their brains. These ﬂies dis-
played short-term memory deﬁcits after sleep deprivation, as well
as abnormal sleep and circadian rhythms (Gajula Balija et al., 2011;
Seugnet et al., 2009).
The relative simplicity of the ﬂy brain and its genetic tractability,
along with the existence of a number of quantitative assays to study
ﬂy behaviour, means there is great untapped potential for studying
non-motor symptoms of PD in this model organism. We examined
learning and memory performance and circadian rhythms in parkin-
null and PINK1-null ﬂies, seeking to determine if these could model
some non-motor aspects of PD as well as the previously-documented
motor defects and neurodegeneration. We also performed elec-
trophysiological recordings of l-LNv clock neurons in control and
mutant genotypes revealing novel mechanisms of action of these
disease-causing genes.
2. Methods
2.1. Fly stocks
Drosophila were raised on cornmeal, molasses and agar medium
under standard conditions. The wild type strain used was CSw −,
obtained from Dr Scott Waddell (University of Oxford). park25
and PINK1B9 null mutants, PINK1RV revertant allele controls and
UAS-PINK1-RNAi ﬂies were all obtained from Dr. Alex Whitworth
(University of Cambridge) (Greene et al., 2003; Park et al., 2006; Yang
et al., 2006). Timeless (tim)-GAL4 ﬂies (stock 27) were obtained from
Dr. Ralf Stanewsky (University of Münster) (Buhl et al., 2016; Chen et
al., 2015).
2.2. Learning and memory experiments
To test learning and memory in ﬂies, we used the olfactory-shock
aversive conditioning protocol (Malik and Hodge, 2014; Tully and
Quinn, 1985). Experiments were conducted at 25 ◦C and 70% humid-
ity in dim red lighting conditions, using the T-maze apparatus. The
odours usedwere 4-methylcyclohexanol (MCH) and 3-octanol (OCT),
dissolved in 10 ml ofmineral oil at concentrations of 1:500 and 1:250
respectively. The negative shock reinforcement used for condition-
ing consisted of 1.5 s pulses of 60 V electric shock, with 3.5 s pauses
between shocks.
For training, groups of 30–50 ﬂies were collected into a training
tube containing a copper grid covering its inside surface. After an ini-
tial resting period of 90 s to acclimatise the ﬂies, the ﬁrst odour for
conditioning was attached to the training tube and was drawn over
the ﬂies by a pump. For shock-paired odours, the electric shock was
simultaneously administered through the copper grid. The ﬂies were
exposed to each odour for 1 min with a 30 s break of fresh air in
between.
For memory tests, ﬂies were kept in food vials before being
reintroduced to the maze for testing. For testing, the ﬂies were intro-
duced into the central compartment of the T-maze. After a 90 s
resting period they were transferred to a decision point from which
they were allowed to move freely into the two arms of the maze,
each with a different odour attached. They were given 2 min to make
their decision, after which time the number of ﬂies in each arm was
counted.
After counting the number of ﬂies making a correct decision
(moving into the arm away from the shock-paired odour) and the
number making a wrong decision, a performance index (PI) was
calculated:
PI =(number of correct ﬂies − number of incorrect ﬂies)
/total number of ﬂies. (1)
A PI of 1 thus indicates 100% avoidance of the shock-paired odour
(perfect learning) and a PI of 0 an even split (no learning). To elimi-
nate any effects of odour bias, the assay was always performed with
two groups of ﬂies, one shocked with MCH and the other shocked
with OCT. The average was then taken of the two scores to give n=1
PI value.
Control experiments were conducted to conﬁrm that any decre-
ments in PI scores were due to a central learning or memory deﬁcit
and not to a peripheral defect in odour acuity or shock reactivity.
To test for odour acuity ﬂies were given 2 min to decide between
an odour at the concentration used for experiments and fresh air
in the T-maze. The percentage of ﬂies avoiding the odour was then
recorded. Flies that can smell normally typically avoid odours and
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instead approach fresh air. To test for shock reactivity ﬂies were
given 2 min to decide between a tube administering an electric shock
and a second identical tube that was not. The percentage of ﬂies
avoiding the shock was then recorded.
2.3. Circadian rhythm experiments
Locomotor activity was recorded using the TriKinetics Drosophila
Activity Monitor (DAM2). In this system, ﬂies are held individually in
small horizontal glass tubes intersected by an infrared beam. When
a ﬂy is active it breaks this beam and activity is recorded (Chen et
al., 2015; Rosato and Kyriacou, 2006; Schlichting et al., 2016). Here,
we recorded activity of male ﬂies on agar food in 30 min bins. Mon-
itors were connected to the computer and placed in an incubator at
25 ◦C and 60–70% humidity. The ﬂies were kept in LD (12:12 h light-
dark cycle) for two full days before being switched to DD (constant
darkness) for a further seven days. Three repeats of this experiment
were conducted on separate occasions to ensure replicability.
Circadian rhythm analysis was performed in Matlab using the
Flytoolbox (Levine et al., 2002b) with some modiﬁcations described
below. Additional statistical analyses were done in GraphPad Prism.
From the data recorded by the DAM system, double-plotted (each
day is plotted twice) actograms were plotted to help visualise how
the activity of the ﬂies varies with time of day. By examining the
actogram for an individual ﬂy, it was classiﬁed as rhythmic if there
was an obvious circadian rhythm to its activity, as arrhythmic if there
was no such rhythm present, or as weakly rhythmic if there was only
partial rhythmicity or if the rhythmicity changed over time.
The data from ﬂies that died before the end of the experiment
were excluded from analysis. The data from the remaining ﬂies were
then ﬁltered using a low-pass Butterworth ﬁlter to eliminate any
periodicities under 4 h. We used autocorrelation analysis to measure
rhythmicity in DD, as has been done by others (Levine et al., 2002a).
This method involves the cross-correlation of a signal with itself in
time, which can then be plotted as an autocorrelogram. Signiﬁcant
periodic variation in this autocorrelogram indicates rhythmicity in
the signal. The strength of any rhythmicity present was assessed by
looking at the height of the third peak in the autocorrelogram, within
a given range of periodicities (between 16 and 32 h in our case), and
using this to calculate a rhythmicity statistic (RS). The RS is the ratio
of the height of the third peak to the absolute value of the 95% con-
ﬁdence interval line. The autocorrelogram also gives an estimate of
the period of any rhythmicity.
To complement this RS value, we also used a value termed the
diurnal/nocturnal index (D/NI), which simply quantiﬁes the distinc-
tion between day time and night time activity levels.
D/NI = (day-time activity − night-time activity)/total activity. (2)
This statistic has the beneﬁt of being intuitive to calculate and inde-
pendent of overall activity levels. It has previously been used by
others to analyse the activity of ﬂies in LD (Kumar et al., 2012). Here
we have modiﬁed its use for analysing data in DD by designating the
‘day-time’ and ‘night-time’ periods for individual ﬂies according to
the period of their rhythmicity, as calculated by the autocorrelation
analysis.
2.4. Electrophysiological recording of clock neurons
Whole-cell current clamp recordings were performed as
described previously (Buhl et al., 2016; Chen et al., 2015; Schlichting
et al., 2016). To visualise the l-LNvs, Pdf::RFP (Ruben et al., 2012)
and a 555 nm LED light were used for control and experimental
stocks. Adult male ﬂies were collected either at Zeitgeber time (ZT)
1–3 (1–3 h after lights-on: day condition) or ZT13–15 (1–3 h after
lights-off: night condition), where ZT0 corresponds to lights-on. For
each genotype and time point brains from at least three different
ﬂies were used.
Whole ﬂy brains were acutely dissected in extracellular saline
solution containing (in mM): 101 NaCl, 1 CaCl2, 4 MgCl2, 3 KCl, 5 glu-
cose, 1.25 NaH2PO4 and 20.7 NaHCO3 at pH 7.2. After removal of the
photoreceptors, lamina, air sacks and trachea, a small incision was
made over the position of the l-LNv neurons in order to give eas-
ier access for the recording electrodes. The brain was then placed
ventral side up in the recording chamber, secured using a custom-
made anchor and neurons were visualised using a ×63 lens on an
upright Zeissmicroscope (Examiner.Z1, Carl ZeissMicroscopy GmbH,
Jena, Germany). l-LNv neurons were identiﬁed on the basis of their
ﬂuorescence, size, morphology and position. Recordings were per-
formed at room temperature (20–22 ◦C) using glass electrodes with
8–18 MY resistance ﬁlled with intracellular solution (in mM: 102
K-gluconate, 17 NaCl, 0.94 EGTA, 8.5 HEPES, 0.085 CaCl2, 1.7 MgCl2
or 4 MgATP and 0.5 NaGTP, pH 7.2) and an Axon MultiClamp 700B
ampliﬁer, digitised with an Axon DigiData 1440A (sampling rate: 20
kHz; ﬁlter: Bessel 10 kHz) and recorded using pClamp 10 acquisition
software (Molecular Devices, Sunnyvale, CA, USA). Chemicals were
acquired from Sigma (Poole, UK).
The liquid junction potential was calculated as 13 mV and sub-
tracted from all the membrane voltages. A cell was included in
the analysis if the access resistance was less than 50 MY. Resting
membrane potential (RMP) and the spontaneous ﬁring rate (SFR)
were measured after stabilising for 2–3 min. The membrane input
resistance (Rin) was calculated by injecting hyperpolarising current
steps and measuring the resulting voltage change. Neuron excitabil-
ity was measured by injecting a 500 ms long positive current pulse
with increasing amplitude up to +40 pA and manually counting the
resulting spikes. The statistical tests were performed using Prism
(GraphPad Software Inc., La Jolla, CA, USA).
3. Results
3.1. PINK1 null ﬂies display a learning impairment, while parkin null
ﬂies display a slower rate of memory decay following acquisition
Learning (two-minute memory) and intermediate-term memory
(two-hour memory) was measured in CSw- wild type and PINK1B9
and park25 mutant ﬂies. Young ﬂies were used for all experiments
presented here: although PD is generally a progressive disorder,
these particular mutations cause an early-onset form of the disease
and non-motor symptoms can be present long before clinical diag-
nosis. Furthermore, reduced longevity and other defects present in
the ﬂies make it logistically diﬃcult to study their behaviour at more
advanced ages.
PINK1B9 ﬂies have signiﬁcantly lower PI scores compared with
wild type, and display a signiﬁcant impairment in two-minute mem-
ory in particular (Fig. 1a), which suggests a problem with memory
acquisition rather than memory retention. Two hours after training,
their PI scores drop to close to 0. Shock reactivity in these ﬂies is nor-
mal and they signiﬁcantly avoid both MCH and OCT, showing that
they can smell both odours at the concentrations relevant for these
experiments (Supplemental Fig. S1). Thus the lowered PI scores can
be assumed to result from some central learning deﬁcit as opposed
to a peripheral sensory deﬁcit.
Unlike PINK1B9 ﬂies, park25 ﬂies do not show a straightforward
learning impairment, but rather an altered rate of decay of memory
following acquisition – while wild type ﬂies show a clear, signiﬁ-
cant decrease in PI scores over 2 h, the decrease in parkin mutants is
small and not statistically signiﬁcant (Fig. 1b). Although odour acuity
is normal, mutant ﬂies do display a small but signiﬁcant reduction
in shock reactivity compared with controls (Supplemental Fig. S1),
which may explain the apparent (but not statistically signiﬁcant)
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Fig. 1. Two-minute and two-hour memory in PINK1 and parkin loss-of-function mutants. (a) Comparing PINK1B9 to wild type performance revealed a signiﬁcant effect of both
genotype (p = 0.0012) and time (p = 0.0011). (b) Comparing park25 to wildtype revealed a signiﬁcant effect of interaction between time and genotype (p = 0.0057) – while wild
type ﬂies display a signiﬁcant difference between two-minute and two-hour memory (p < 0.01), this was not the case for park25 ﬂies. Data were analysed using two-way ANOVA
with matching by day of experiment and Bonferroni’s multiple comparisons tests (n = 7 experiments for each data point; * p < 0.05; error bars indicate standard error of the
mean (SEM)).
reduction in PI scores for two minute memory. However, this can-
not clearly account for a slowing of memory decay and an apparent
enhancement of PI scores for two hourmemory. An additional exper-
iment examining three-hour memory in parkin null mutants and
both wild type and heterozygous controls further conﬁrmed this
trend of slower memory decay in the mutant ﬂies (Supplemental
Fig. S2). The fact that heterozygous controls performed similarly to
wild type also means that any phenotypes seen in the mutants are
highly unlikely to be due to some other background mutation.
3.2. Both PINK1 and parkin null ﬂies display weakened circadian
rhythms in locomotor activity
We monitored the locomotor activity of 1–3 day old wild type
and PINK1B9 and park25 mutant ﬂies to see if they displayed nor-
mal circadian rhythmicity in their cycles of activity and rest in the
absence of external time cues.
Wild type ﬂies show characteristic morning and evening peaks in
activity in LD, and maintain a rhythm of daytime activity and night-
time inactivity in DD, with a period of just under 24 h (as illustrated
by the leftwards trend in the actogram) (Fig. 2). The mutant geno-
types display relatively normal activity in LD, with a slight reduction
in the morning and evening peaks that can be attributed to their
impaired locomotor activity (Fig. 2b). The park25 ﬂies also appear to
have slightly elevated baseline activity levels, particularly at night.
Both mutant genotypes do maintain some discernible rhythmicity
in their activity in DD (Fig. 2a and c). However, there appears to be
less of a distinction between the periods of activity and inactivity,
and relative night-time activity seems to be elevated. park25 ﬂies also
showed overall higher levels of activity.
Representative actograms for individual wild type and mutant
ﬂies can be seen in Fig. 3a and the corresponding autocorrelograms
in Fig. 3b.Wild type ﬂies, on thewhole, show a robust rhythm of day-
time activity and night-time inactivity in DD. PINK1B9 ﬂies are more
likely to lack such a rhythm and park25 ﬂies tend to maintain some
sort of circadian rhythm, but with less of a distinction between their
day-time and night-time activity. The overall proportions of rhyth-
mic, weakly rhythmic and arrhythmic ﬂies for each genotype can be
seen in Fig. 3c. While the majority of wild type ﬂies displayed robust
rhythmicity in DD, this was not the case for the mutant ﬂies: most
PINK1B9 ﬂies were totally arrhythmic, while more of the park25 ﬂies
had a tendency to be weakly rhythmic.
PINK1B9 mutants showed signiﬁcant reductions in both RS and
D/NI values compared with wild type, reﬂecting the reduced rhyth-
micity seen through observation (Fig. 4a and b). On the other hand,
the park25 ﬂies did not show a signiﬁcant reduction in RS values,
but showed a large, highly-signiﬁcant reduction in D/NI values. It
seems that these ﬂies are capable of maintaining some sort of circa-
dian rhythm in DD, but that this does not manifest itself in the usual
pattern of day-time activity and night-time rest. The period length
of rhythms in both mutant genotypes was normal (Fig. 4c). Ageing
did not affect the circadian rhythms of PINK1 null mutants any more
than it did those of wild type controls, further justifying the focus on
young ﬂies (Supplemental Fig. 3). Aged parkin null ﬂies did not live
long enough for experiments to be completed.
3.3. PINK1 and parkin null ﬂies show altered clock neuron
electrophysiology
Since manipulation of PD genes led to impairments in circadian
locomotor behaviour, we investigated potential underlying causes
by recording from l-LNv clock neurons during the day and at night
(Fig. 5) and measured electrophysiological properties of these cells
(Fig. 6). As previously reported, wild type l-LNvs showed a more
depolarised resting membrane potential (RMP) and a higher sponta-
neous ﬁring rate (SFR; day/night ratio 2.83) in the day than at night,
while input resistance (Rin) and the response to an injected current
pulse (+40 pA) did not differ signiﬁcantly (Buhl et al., 2016).
l-LNv neurons in PINK1B9 mutants also showed a day/night differ-
ence in SFR (day/night ratio 3.12) but with a higher ﬁring frequency,
especially in the daytime. The day/night difference in RMP was
slightly less pronounced than in wild type. While Rin values were
similar towild type neurons, PINK1B9 l-LNvsweremore excitable and
ﬁred much more in response to injected current.
On the other hand, park25 l-LNvs did not show a day/night dif-
ference in SFR (day/night ratio 1.05), and had a slightly reduced
difference in RMP. Rin and current responses were similar to wild
type neurons. This shows that mutations in PINK1 and parkin genes
differentially affect neurophysiological properties of clock neurons.
4. Discussion
We have shown that the established PINK1 and parkin null
Drosophila models of PD show changes in learning and memory and
in circadian rhythms of locomotor activity, as well as underlying
electrophysiological abnormalities in clock neurons. The persistence
of these phenotypes when compared to additional heterozygous or
revertant allele controls means they are unlikely to arise from other
background mutations (Supplemental Figs. 2 & 4). This opens up
the possibility of using these models to gain a better understanding
of the mechanisms underlying non-motor symptoms of the disease,
which are currently poorly understood, and are increasingly being
highlighted as worthy of more detailed characterisation in animal
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Fig. 2. Averaged activity patterns of wild type and PINK1 and parkin loss-of-function mutant ﬂies in LD and DD conditions. The data were pooled from three separate rounds of
recording. (a) Averaged double-plotted actograms of wild type and mutant ﬂies over two days of LD and seven days of DD. (b) Averaged activity histograms for two days of LD
conditions. (c) Averaged activity histograms for the ﬁrst two days of DD conditions. Activity was measured in beam crosses per hour. The grey shading indicates times when lights
were turned off. The red dots indicate SEM. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
models so that new targets for treatment may be identiﬁed (Dawson
et al., 2010).
Our PD ﬂies showed learning and memory abnormalities, cor-
relating with the presence of cognitive impairments in patients
(Barone et al., 2011; Frank et al., 2004). PINK1 null ﬂies showed lower
memory scores compared with controls, and displayed a defect in
memory acquisition in particular. This is not surprising considering
the crucial role DA is known to play in reinforcement learning across
species, in particular in providing the reinforcement signal or ‘reward
prediction error’ (Schultz et al., 1997; Waddell, 2010). The results for
parkin null ﬂies did not show a simple impairment in the same way,
but rather a slowing ofmemory decay. A possible explanation for this
may come from recent research inDrosophila that implicates DA neu-
rons in a forgetting process. According to this theory, ongoing tonic
activity in a subset of DA neurons after learning induces the decay of
memories, and inhibiting this activity boosts memory retention over
time (Berry et al., 2012). It is conceivable that mutations in parkin
might lead to dysfunction of these neurons, impairing their activity
and thus slowing memory decay.
Although circadian rhythm defects are not usually explicitly cited
as a feature of PD, up to 64% of patients report sleep problems and
circadian processes are an important regulator of the sleep-wake
cycle (Barone et al., 2009; Borb and Achermann, 1999). Disruptions
to melatonin and cortisol regulation also provide evidence for a cir-
cadian component to sleep disturbances seen in the disease (Breen
et al., 2014; Mattis and Sehgal, 2016; Videnovic et al., 2014). Further-
more, circadian disruptions have also been found in rodent PD mod-
els: mice overexpressing a-synuclein show fragmented or reduced
circadian locomotor activity accompanied by reduced ﬁring of their
clock neurons, while the MitoPark mouse shows a progressive loss
of clock neurons accompanied by profound disruptions to locomotor
rhythms under constant conditions (Fifel and Cooper, 2014; Kudo et
al., 2011; Willison et al., 2013).
Our results showed defects in the circadian rhythms of locomotor
activity in both PINK1 and parkin null ﬂies under constant darkness
conditions. A large proportion of PINK1 null ﬂies were found to be
totally arrhythmic, while the parkin null ﬂies tended to show more
of a weakening of rhythms, along with an overall increase in activity.
Both mutant genotypes showed less of a distinction between periods
of activity and inactivity, losing a recognisable day/night pattern. The
relative increase in night-time activity in mutant ﬂies is especially
noteworthy considering the presence of locomotor defects – if any-
thing, we would have expected that any problems with movement
would lead to lower levels of activity. Although detailed sleep anal-
ysis was beyond the scope of this study, any increase in night-time
activity naturally suggests a possible reduction in sleep, correlat-
ing with the symptoms of insomnia seen in humans. A reduction in
nighttime sleep has also been observed in an a-synuclein ﬂy model
of PD (Gajula Balija et al., 2011). Unlike this model, however, the
PD models examined here did not show any alterations in period
length, suggesting that the nature of the circadian defect seen may
be underlied by slightly different mechanisms.
Our behavioural results are complemented by our detection of
electrophysiological abnormalities in l-LNv clock neurons, which are
thought to mediate arousal behaviour (Parisky et al., 2008). The
hyperexcitability of these neurons in the PINK1 null ﬂies may be
responsible for interrupting their sleep during the night period, thus
disrupting their circadian rhythm. Indeed, others have found that
hyperexcitation of these neurons does disrupt sleep (Sheeba et al.,
2008). The lack of a day/night difference in ﬁring rate in the parkin
null ﬂies is particularly interesting, as it mirrors the lack of such a dis-
tinction between their locomotor activity levels during the day and
night periods.
It remains to be determined to what extent these phenotypes
are due to DA deﬁciency as opposed to defects intrinsic to the clock
neurons themselves. On the one hand, the presence of abnormalities
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Fig. 3. Activity patterns of individual ﬂies in the absence of external time cues. (a) Representative double-plotted actograms of individual ﬂies typical of each genotype over two
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in l-LNv clock neuron activity, in particular the hyperexcitability of
those in PINK1 null ﬂies, does suggest the presence of some intrin-
sic changes in these neurons. Indeed, we have found evidence that
knocking down PINK1 in clock neurons using RNAi results in a weak-
ening of circadian rhythms (Supplemental Fig. 5). Furthermore, the
suggestion that lowered DA levels alone might lead to sleep disrup-
tion is somewhat at odds with the current theory of DA mediating
wakefulness in ﬂies (Kume et al., 2005; Ueno et al., 2012). On the
other hand, the l-LNv clock neurons are only one part of a larger net-
work mediating the sleep-wake cycle, and it is likely that the effects
we see on spontaneous ﬁring rates are in some part due to network
effects. Interestingly, l-LNv neurons express DA receptors, and DA
deﬁcient ﬂies have been shown to have weakened circadian rhythms
(Hirsh et al., 2010; Shang et al., 2011). Furthermore, simply disrupt-
ing DA neuronal signalling in the absence of cell death has been
shown to produce circadian activity phenotypes similar to those
observed in the a-synucleinmodel mentioned above (Gajula Balija et
al., 2011). It is alsoworth noting that the period of behavioural rhyth-
micity in the PD ﬂies examined here was not signiﬁcantly altered
– signiﬁcant alterations in period length are a typical indication of
molecular clock dysfunction. The results are, however, consistent
with the disrupted clock neuron excitability affecting clock output.
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Although PD is typically thought of as speciﬁcally affecting DA
neurons, a whole range of other neurons and neurotransmitter
systems are increasingly thought to be affected, as reﬂected in the
widening variety of targets for emerging drug treatments (Barone,
2010; Brichta et al., 2013). For instance, degeneration of wake-
active hypocretin neurons in the hypothalamus may result in sleep
Fig. 6. Quantitative analysis of electrophysiological properties of l-LNv clock neurons in wild type and mutant ﬂies expressing Pdf::RFP, in both day and night conditions.
(a) Analysis of resting membrane potential (RMP) values showed a signiﬁcant effect of time of day (p < 0.0001) but no effect of genotype. (b) Analysis of spontaneous ﬁring
rate (SFR) values showed a signiﬁcant effect of interaction between time of day and genotype (p < 0.001). PINK1B9 neurons have a higher ﬁring rate and park25 neurons do not
show a day/night difference. (c) Analysis of input resistance (Rin) found a possible, but non-signiﬁcant difference depending on time of day (p = 0.066) but no effect of genotype.
(d) Analysis of responses to an injected current pulse (f+40 pA) showed a signiﬁcant effect of genotype (p ¡ 0.0001), with PINK1B9 mutants beingmore excitable. Data were analysed
using two-way ANOVA and Bonferroni’s multiple comparisons tests (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; error bars indicate standard deviations (SD)).
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dysregulation (Fronczek et al., 2007; Thannickal et al., 2007). The
extensive genetic toolbox available in the ﬂy should thus prove use-
ful for dissecting apart the roles and interactions of these different
systems.
A remaining intriguing aspect of our results is the qualitative dif-
ferences seen between the twomutant genotypes, considering PINK1
and parkin are thought to act in the same pathway. We offer two
potential explanations for this. Firstly, it may be the case that the
pathology is simply more severe in PINK1 null ﬂies than in parkin
null ﬂies. Thus, with regard to memory performance, it may be the
case that DA neurons in parkin null ﬂies are impaired only to the
point of reducing their ongoing tonic activity without impairing their
ability to produce phasic activity suﬃcient to provide a reinforce-
ment signal, while those in PINK1 null ﬂies are impaired to the point
that phasic activity is also affected. This would highlight the need to
take into account the subtleties of neuromodulation in neural circuits
controlling behaviour, especially when developing treatments that
alter neuromodulatory pathways. Indeed, some studies in humans
show that reinforcement learning is impaired in PD patients both on
and off their medication, but in different ways (Frank et al., 2004).
The behavioural circadian rhythm defect in PINK1 null ﬂies might
also be thought of as more severe, as a higher proportion of these
mutants were arrhythmic than the parkin null ﬂies. In humans, PINK1
PD might be thought of as more severe than parkin PD to the extent
that the latter does not typically present with Lewy body pathology
(Kalinderi et al., 2016). The other possible explanation for the dif-
ference is that these two genes have independent roles outside of
the mitochondrial quality control pathway in which they are most
usually studied, and that this pathway is perhaps more complicated
than previously thought. Indeed, our understanding of the function
of the PINK1/parkin pathway in an in vivo setting is still somewhat
lacking, and different mitochondrial phenotypes have been found
under normal physiological conditions in ﬂies compared with cul-
tured cells (Devireddy et al., 2015; Grenier et al., 2013; Sung et al.,
2016). Evidence for at least one diverging pathway involving PINK1
independent from parkin comes from a study into the phenotypic
effects of the ﬂy homolog of HtrA2, which has been associated with
an increased susceptibility to PD (Tain et al., 2009).
Crucially, non-motor symptoms are often present years before
the onset of motor symptoms and the clinical diagnosis of PD in
humans. This is especially true of sleep disturbances such as RBD:
the majority of RBD sufferers will go on to develop PD or a related
disorder (Schenck et al., 2013). Therefore, it is increasingly thought
that sleep disorders such as RBD may represent a prodromal phase
of PD that precedes clinical onset of the disease by on average
14 years (dos Santos et al., 2015; Iranzo et al., 2013). Thus non-
motor disorders of PDmay offer a presymptomatic window for study
and treatment, allowing earlier intervention as well as the develop-
ment of drugs that could actually target the causes of the disease as
opposed to merely treating the symptoms when irreversible brain
damage has already taken place. It has even been suggested that
sleep and circadian regulation might be used as a therapeutic tool to
treat the disease (Mattis and Sehgal, 2016; Videnovic et al., 2014).
5. Conclusions
The disruptions to non-motor behaviour we have detected in our
PD ﬂies is interesting on a number of fronts. Our study paves the
way for further work that may help us understand the mechanisms
underlying these neglected aspects of the disease and identify tar-
gets for new treatments to address them. Not only this, but in doing
so, we may gain a greater understanding of the role of the neuro-
transmitters involved; for instance, the subtly different roles played
by DA in learning andmemory. Most excitingly, the fact that many of
these symptoms arisemuch earlier than the onset of motor problems
also gives rise to the possibility that studying them will bring more
general insights into the etiology of the disease, potentially leading
to the development of treatments that can halt disease progression
entirely before irreversible neuronal loss occurs.
Finally, the fact that we have detected any non-motor dysfunc-
tions at all is interesting in itself. The presence of such disruptions
in ﬂy models of the disease cannot be due to side effects of medica-
tion and is less likely to be linked to symptoms such as depression or
external environmental factors. As such, it provides support for the
idea that cognitive and circadian disruptions really are an intrinsic
aspect of the disease.
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